Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Letermovir by Merck for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
Letermovir is under clinical development by Merck and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS). According...
Data Insights
Letermovir by Merck for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
Letermovir is under clinical development by Merck and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS). According...